Clinical Trials

CONTACT US

Nicole Finley, MSN, RN
Lead Clinical Research Coordinator
304.691.1830

Explore the list of clinical trials currently enrolling at the Marshall Clinical Research Center. To learn more about a specific study, click on the description to view details on ClinicalTrials.gov or contact the listed study coordinator for direct assistance.

Active Clinical Trials

Study ID	PI	Description	Contact Information
NCT03012776	Dr. Nicolas Phan	A Pivotal Study of the Premia Spine TOPS System (TOPS IDE)	Jessica Merrick, RN
NCT06388421	Dr. Amro Al-Astal	DeciPHer-ILD (GMS-PH-401): A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)	Amber Vickers, RN
NCT04965675	Dr. Jorge Lopez	PROSPECT II - Interventional, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of IV eptinezumab in adolescents (12-17 years) for the preventive treatment of chronic migraine	Jessica Merrick, RN
NCT05643534	Dr. Xavier Villa	RALLY - (Ten-01-304) A 12 week, Randomized, Double blind, placebo controlled, phase 3 study to assess the safety and efficacy of a Tenapanor for the treatment of irritable bowel syndrome with constipation (IBS-C) in pediatric patients 12 to less than 18 years old	Jessica Merrick, RN
NCT06553547	Dr. Xavier Villa	RALLY 202: (Ten-01-202) A 4-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Pediatric Patients 6 to Less than 12 Years Old	Jessica Merrick, RN
NCT05905926	Dr. Xavier Villa	Rall-Y 306: TEN-01-306 An Open-Label Long-Term Safety Study of Tenapanor for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Pediatric Patients 6 to Less than 18 Years Old	Jessica Merrick, RN
NCT05889624	Dr. Jorge Lopez	REACH - Responding with Evidence and Access for Childhood Headaches: The REACH Study	Hillary Salava, RN
NCT06819891	Dr. Umapathy Sundaram	SIBERITE-2 (GA45332): A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study to Access the Efficacy and Safety of Induction Therapy with RO7790121 in Patient with Moderately to Severely Active Crohn's Disease	Nicole Finley, MSN, RN, ACCNS-AG
NCT06625060	Dr. Jorge Lopez	MERANTI: A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults	Gina Finley, Pharm D
NCT07035431	Dr. Wesam Frandah	Endo-SPONGE: A Prospective Multicenter Trial Evaluating the Safety and Effectiveness of Endo-SPONGE for the Treatment of Anastomotic or Hartmann's Stump leakages in the Lower Pelvic Area	Nicole Finley, MSN, RN, ACCNS-AG Amber Vickers, RN
Not assigned at this time	Dr. Paul Ferguson	CONCEIRTO: An Observational Study To Determine The Incidence Of Injection Reactions Among Patient With Multiple Sclerosis Treated with Ocrelizumab Subcutaneous

PI Initiated Clinical Trials

IRB Number	PI	Description
499630	Dr. Alan Koester	AVANTA (SRTMMCP)
463451	Dr. Alan Koester	AVANTA (SRTMPIP)
451197	Dr. Umapathy Sundaram	Marshall University School of Medicine Informatics for Integrating Biology to the Bedside (I2B2)
964144	Dr. Umapathy Sundaram	Regulation of intestinal nutrient and electrolyte transport in chronic diseases
2233227	Dr. Jorge Lopez	Efficacy and Safety of Greater Occipital Nerve Blocks in Migraine Treatment for Adolescents in a Rural Population
2068017	Dr. Umapathy Sundaram	Metabolic Syndrome and colon cancer
2084009	Dr. Umapathy Sundaram	Metabolic Syndrome and its Impact on the Incidence and Progression of Barrett's Esophagus and Esophageal Cancer: A Retrospective Study
2272843	Dr. Umapathy Sundaram	Metabolic Syndrome and NAFLD/NASH in Appalachian Population

Updated May 8, 2026